Pulmonx (LUNG) Expected earnings per share growth for next year

Logistics disruptions and sanctions are hindering the sales of Pulmonx Corporation (LUNG) systems, confirming the projected net profit trend, where this figure equals 5.10. Global sales of pulmonary valves across various regions provide stability. The use of multiple contract manufacturers adds further resilience, completely eliminating dependence on a single plant.
Analytical breakdowns for Pulmonx Corp (LUNG)

This indicator measures the consensus forecast for net earnings per share growth, reflecting market expectations for future profitability. By analyzing the history of forward EPS estimates, an investor can track the real-time revision of financial targets by analysts. For Pulmonx Corporation (LUNG), this trend depends critically on the rate of medical technology adoption by physicians and insurance reimbursement conditions.